LACTERA Therapeutics, Inc.

HOME

Transforming Wound Healing Through Science

LACTERA Therapeutics, Inc. is a biotechnology company focused on advancing innovative solutions for wound healing, tissue repair, and regenerative healthcare.

Built upon patented technologies, clinical experience, and real-world market validation, LACTERA is dedicated to improving outcomes for patients suffering from acute and chronic wounds.

Our mission is to bridge scientific innovation with clinical practice and deliver effective healthcare solutions to global markets.

Biotechnology laboratory research.

Key Highlights

Focus Areas

Global Vision

To become a globally recognized biotechnology company delivering innovative wound care and regenerative solutions that improve patient outcomes worldwide.

ABOUT US

Company Overview

LACTERA Therapeutics, Inc. is a biotechnology company headquartered in the United States and focused on the development, commercialization, and international expansion of innovative wound healing technologies.

The company was established to bring clinically validated healthcare innovations into global markets through strategic partnerships, scientific excellence, and evidence-based product development.

By integrating biotechnology, intellectual property, clinical expertise, and commercialization capabilities, LACTERA aims to address significant unmet needs in wound care and tissue repair.

Founding Leadership Team

United by Science. Driven by Patients. Focused on Global Impact.

Our founding leadership team brings together decades of experience in business leadership, biotechnology innovation, and clinical medicine.

United by a shared commitment to improving patient outcomes, the team combines scientific research, clinical expertise, and global business strategy to accelerate the development and commercialization of next-generation wound care and regenerative medicine technologies.

We believe meaningful healthcare innovation requires more than breakthrough science. It requires strong clinical evidence, scalable commercialization, and trusted international partnerships.

Together, our leadership team is building a global medical technology platform dedicated to transforming innovative research into real-world healthcare solutions.

Our Leadership

Founder & Chief Executive Officer: Leads the company’s global strategy, international business development, investor relations, and corporate growth. With extensive experience in cross-border business development, the CEO is responsible for building strategic partnerships and accelerating the worldwide commercialization of innovative medical technologies.

Co-Founder & Chairman: Leads technology innovation, product development, intellectual property strategy, and corporate governance. With extensive experience in biotechnology and healthcare management, the Chairman has dedicated his career to advancing fermentation biotechnology, bioactive materials, wound healing, and regenerative medicine.

Co-Founder & Chief Medical Officer: Leads medical strategy, clinical research, scientific affairs, and international medical collaborations. As a reconstructive surgeon, wound care specialist, and academic leader, the Chief Medical Officer provides clinical leadership, scientific validation, and evidence-based guidance to support the company’s medical innovation platform.

Medical & Scientific Advisory Board

Mission

To improve patient recovery and quality of life through innovative biotechnology solutions that support wound healing and tissue regeneration.

Vision

One Vision. Three Disciplines.

Business, technology, and medicine are the three pillars of meaningful healthcare innovation. By integrating global business strategy, biotechnology innovation, and clinical excellence, our founding leadership team has established a comprehensive platform spanning scientific discovery, clinical validation, regulatory readiness, and commercial execution.

Together, we are committed to delivering innovative healthcare solutions that improve lives and create lasting value for patients, healthcare providers, and partners worldwide.

Core Values

Corporate Structure

LACTERA Therapeutics, Inc. is organized as a Delaware C-Corporation and serves as the global commercialization and business development platform for international expansion opportunities.

TECHNOLOGY • PRODUCTS

Technology Platform

Proprietary Wound Healing Technology

LACTERA’s technology platform focuses on supporting natural healing processes through advanced biotechnology approaches designed to enhance tissue repair and recovery.

The platform has been developed through years of research, product development, clinical experience, and intellectual property protection.

Technology Advantages

Target Applications

Wound care technology image.

Future Development

LACTERA continues to expand its technology platform through research collaborations, product innovation, and international clinical partnerships.

CLINICAL & RESEARCH

Clinical Evidence

Clinical Experience

LACTERA’s technology has accumulated clinical experience through professional healthcare applications and real-world utilization.

The company continues to collect and evaluate clinical insights that support product improvement and future research initiatives.

Clinical evidence publication.
Clinical evidence table.
Clinical evidence chart.

Chao-Chih Yang, Megn-Si Wu, Honda Hsu, Management of diabetic foot ulcers using topical probiotics in a soybean-based concentrate: A multicentre study. J Wound Care. 2023 Dec 1;32:S16-S21.

Clinical research publication.

Honda Hsu, Chao-Chih Yang, Shih-Ming Huang, Meng-Si Wu, Hui-e Yao, Yi-Wei Lin, Topical Probiotics in Soybean Concentrate for Diabetic Foot Ulcers: A Randomised Controlled Trial. British Journal of Dermatology, Volume 194, Issue 6, June 2026, Pages 1192–1194.

Evidence-Based Development

We believe that meaningful healthcare innovation requires scientific validation and clinical relevance.

Our development strategy emphasizes:

Research Collaboration

LACTERA actively seeks collaboration with:

Intellectual Property

Intellectual Property Strategy

Intellectual property represents a core asset of LACTERA Therapeutics. We maintain a comprehensive strategy focused on protecting innovation and supporting long-term value creation.

IP Portfolio:

Intellectual property certificate.

Competitive Advantage: Our intellectual property portfolio is designed to support sustainable growth, product differentiation, and international commercialization opportunities.

PARTNERSHIPS

Global Market Presence

Commercial Experience

LACTERA’s technology has been introduced into healthcare markets and has generated practical commercial and clinical experience. These market activities provide valuable insights into healthcare provider needs, product performance, and future expansion opportunities.

International Expansion Strategy

The company is actively evaluating opportunities across:

United States / Israel / Ukraine / Taiwan / Asia-Pacific Markets

Strategic Global Healthcare Networks & Growth Priorities:

Clinical Partnerships ｜ Market Access

Distribution Expansion ｜ Technology Licensing

Regulatory Development ｜ Strategic Investment

Licensing & Partnership Opportunities

LACTERA is open to exploring:

Investor Relations

Investment Opportunity

LACTERA Therapeutics is building a biotechnology platform focused on addressing significant global needs in wound healing and regenerative healthcare.

Areas of Interest for Investors:

Strategic Investors ｜ Healthcare Investors ｜ Biotechnology Investors

Family Offices ｜ Corporate Venture Groups ｜ International Healthcare Partners

Use of Capital:

Technology Development ｜ Clinical Expansion ｜ Regulatory Activities

Market Development ｜ Strategic Partnerships ｜ International Commercialization

CONTACT

Contact Channels

Investor Relations: investors@lactera.com

Partnership Inquiries: partnerships@lactera.com

General Information: info@lactera.com

Advisory Network Expansion

LACTERA continues to expand its advisory network through collaborations with healthcare professionals, researchers, and industry experts.

Forward-Looking Statements Disclaimer:

This website contains forward-looking statements regarding LACTERA’s future development, clinical expansion, and regulatory activities. These statements are based on current expectations and involve inherent risks and uncertainties. Actual results may differ materially from those anticipated. LACTERA undertakes no obligation to publicly update any forward-looking statements.